\"International orthopaedics\", the SICOT flag-carrier, over one million downloaded papers in 2024, unprecedented volume and visibility, facts about the journal that prepares its fiftieth volume starting January 2026.
AuteursScarlat MM, Hernigou P, Hinsenkamp M, Mavrogenis A, Khanduja V
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.
AuteursMekinian AM, Georgin-Lavaille S, Ferrada MA, Savic S, Koster MJ, Kosmider O, Comont T, Heilblig M, Arostegui JI, Bosco A, Bourguiba R, Calvo KR, Cargo C, Cattaneo C, Chasset F, Coelho H, Campochiaro C, Crisafulli F, Ducharme-Benard S, Faria R, Franceschini F, Frassi M, Groarke EM, Gurnari C, Hakobyan Y, Jamilloux Y, Jurcut C, Kirino Y, Kulasekararaj A, Kunimoto H, Madigan LM, Mann HF, Marvisi C, Milchert M, Morais S, Sockel K, Muratore F, Nakajima H, Patnaik MM, Regadas L, Robin M, Rutgers A, Salvarani C, Sammel AM, Seebach J, Sujobert P, Tomelleri A, Urbanski G, Vandergheynst F, Vieira R, Viswanatha DS, Więsik-Szewczyk E, Diral E, Terrier B, Patel BA, Fenaux P, Grayson PC, Beck DB
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis.
AuteursRossignol P, Zannad F, Massy Z, Azizi M, Chorfa F, Coadic J, Ferreira JP, Saraiva F, Mottier D, Guillemin F, Ngueyon Sime W, Bouali S, Rossignol B, Nortier J, Simon I, Robino C, Davin M, Bataille PM, Chantrel F, Castin N, Esnault V, Kazes I, Hannedouche T, Kamar N, Achard JM, Fenerol C, Achard-Hottelart C, Dimitrov Y, Girerd N, Maucourt-Boulch D, Frimat L
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis.
AuteursMerkel PA, Nair PK, Khalidi N, Terrier B, Hellmich B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Pagnoux C, Specks U, Börjesson Sjö L, Ho CN, Jison M, McCrae C, Necander S, Rodríguez-Suárez E, Shavit A, Walton C, Wechsler ME
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.
AuteursSitbon O, Sahay S, Escribano Subías P, Zolty RL, Kingrey JF, Ryan JJ, Sobol I, Sood N, Benza RL, Channick RN, Chin KM, Frantz RP, Ghofrani HA, Hemnes AR, McLaughlin VV, Vachiéry JL, Zamanian RT, Ter Veer A, Roscigno RF, Mottola D, Parsley E, Aranda R, Zisman LS, Howard LS
A new mini-invasive surgical treatment for Peyronie's disease: mechanically processed lipoaspirates as regenerative therapy.
AuteursBerdondini E, Giuseppe M, Margara A, Rigatti P, Voce S, Reale G, Saltutti C, Maroccia M, Martínez-Salamanca JI, Gacci M, Camera PAD, Tosco L, Eissa A, Trivisonno A, Mondaini N, Bettocchi C, Silvani M
